Nanotechnology Now

Our NanoNews Digest Sponsors







Heifer International

Wikipedia Affiliate Button


Home > Press > Ensysce Biosciences Inc. Appoints Dr. D. Lynn Kirkpatrick as President and CEO

Abstract:
Ensysce Biosciences Inc. announced today the appointment of Dr. Lynn Kirkpatrick as President and CEO. Dr. Kirkpatrick has an extensive background in targeted small molecule cancer drug development, and has brought three agents from bench to bedside. Co-founder of ProlX Pharmaceuticals, Dr. Kirkpatrick was CEO from 1999 until its acquisition by Biomira Inc. in 2006. From 2006 through 2008 she was CSO of the merged company, which changed its name to Oncothyreon Inc. in 2007.

Ensysce Biosciences Inc. Appoints Dr. D. Lynn Kirkpatrick as President and CEO

Houston, TX | Posted on January 5th, 2009

"Dr. Kirkpatrick is a tremendous addition to our company," said Bob Gower, Chairman of Ensysce. "Lynn brings a vast array of skills that will help move Ensysce technology rapidly forward building value in the company and moving new technologies to the forefront of cancer treatment."

Ensysce Biosciences, a Houston, TX based nanotechnology company, is focused on the use of carbon nanotubes for therapeutics in the area of cancer treatment. The company has an extensive carbon nanotube-related, worldwide intellectual property portfolio, including IP developed at Rice University by the late Nobel Prize winner Dr Rick Smalley.

Carbon nanotubes provide a means to deliver large active molecular agents without modification through natural barriers within the body and specifically into cancer cells. "This use of carbon nanotubes has been demonstrated in animal studies by our group of collaborators," said Dr. Kirkpatrick. "We have been able to form stable complexes with numerous active entities including short interfering RNA (siRNA) and we believe our current research efforts to tailor their transport and release will ensure a therapeutic benefit as well as eliminating off target effects. Beside delivery, we are exploring other applications of carbon nanotubes to enhance cancer therapies and believe we will enter clinical trials in the next 12 to 18 months."

Ensysce currently has research collaborations with leaders in both the carbon nanotube technology field as well as cancer drug development at M. D. Anderson Cancer Center, Stanford University and Rice University. "siRNA, the most intriguing recent development for cancer treatment has issues with adequate cellular delivery," said Dr. Garth Powis. "Our efforts to use carbon nanotubes to deliver these macromolecules have demonstrated that we can readily transport siRNA into cancer cells with subsequent biological activity. Those are important steps."

Collaborations with Dr. Hongie Dai from Stanford University have also shown that carbon nanotubes can be used to deliver established cancer drugs resulting in tumor regression in animal studies. The complexes provided a significant therapeutic benefit for agents such as taxol and doxorubicin, demonstrating excellent proof of principle of this exciting novel technology.

####

About Ensysce Biosciences Inc.
Ensysce Biosciences a privately held nanotechnology company in Houston, TX founded in 2008, is focused on the use of fullerene carbon nanotubes for therapeutic applications specifically in cancer.

For more information, please click here

Contacts:

Ensysce Biosciences Inc., Houston
Dr. Bob Gower
713-932-6867

or
Dr. Lynn Kirkpatrick
713-864-7512

Copyright © Business Wire 2008

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

Glowing Plant Releases Maker Kit, Enabling Anyone to Make a Glowing Plant at Home: Glowing Plant seeks funds via crowdfunding and raises almost $400,000 May 23rd, 2013

IDTechEx launches online Market Intelligence Portal May 23rd, 2013

UofL scientists uncover how grapefruits provide a secret weapon in medical drug delivery May 22nd, 2013

Atomic-Scale Investigations Solve Key Puzzle of LED Efficiency: MIT and Brookhaven Lab scientists use electron microscopy imaging techniques to settle a solid-state controversy and raise new experimental possibilities May 22nd, 2013

Nanotubes/Buckyballs

UC Riverside scientists discovering new uses for tiny carbon nanotubes: Adding ionic liquid to nanotube films could build smaller gadgets, and create more cost effective 'Smart Windows' that darken in bright sun May 15th, 2013

Development know-how is made available to collaboration partners: Bayer MaterialScience brings nano projects to a close May 8th, 2013

Next-generation transistor outperforms other carbon-based designs May 7th, 2013

Ubiquitous engineered nanomaterials cause lung inflammation, study finds: Substances are used in everything from paint to sporting equipment May 6th, 2013

Nanomedicine

UofL scientists uncover how grapefruits provide a secret weapon in medical drug delivery May 22nd, 2013

Single-Cell Transfection Tool Enables Added Control for Biological Studies: McCormick researchers develop method of delivering molecules into targeted cells May 22nd, 2013

How Gold Nanoparticles Can Help Fight Ovarian Cancer May 21st, 2013

MU Researchers Develop Radioactive Nanoparticles that Target Cancer Cells: This is an early step toward developing therapies for metastasized cancers, MU scientist says May 21st, 2013

Announcements

Glowing Plant Releases Maker Kit, Enabling Anyone to Make a Glowing Plant at Home: Glowing Plant seeks funds via crowdfunding and raises almost $400,000 May 23rd, 2013

IDTechEx launches online Market Intelligence Portal May 23rd, 2013

UofL scientists uncover how grapefruits provide a secret weapon in medical drug delivery May 22nd, 2013

Atomic-Scale Investigations Solve Key Puzzle of LED Efficiency: MIT and Brookhaven Lab scientists use electron microscopy imaging techniques to settle a solid-state controversy and raise new experimental possibilities May 22nd, 2013

Appointments/Promotions/New hires/Resignations/Deaths

Solid-State Lighting Expert Dr. Bernhard Stapp Named To Board of Pioneering LED Technology Developer Aledia: Former OSRAM General Manager and CTO Has Played Key Role In Industry’s Evolution, Will Aid Aledia’s Move Towards Industrialization May 22nd, 2013

Applied Nanotech Seeks New Chief Executive Officer: New Leader Needed for Next Phase of Growth May 10th, 2013

Cambrios Taps Sriram Peruvemba to Oversee Worldwide Marketing May 8th, 2013

TMC Names Murugesh Thimmanna National Sales Manager, India April 25th, 2013

NanoNews-Digest
The latest news from around the world, FREE





  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More












ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project








abbigliamento uomo
Computer Accessories
© Copyright 1999-2013 7th Wave, Inc. All Rights Reserved PRIVACY POLICY :: CONTACT US :: STATS :: SITE MAP :: ADVERTISE